University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Michael S. Conte

Michael S. Conte, M.D.

Co-director of the Heart and Vascular Center

Dr. Michael Conte, a vascular surgeon, is co-director of the UCSF Heart and Vascular Center and chief of Vascular and Endovascular Surgery. He specializes in diseases of the aorta and its major branches, aneurysms, carotid artery disease and peripheral artery disease (PAD). He also treats diabetic vascular disease and performs complex revascularization to preserve limb function and prevent amputation. Conte led the largest multi-center clinical trial to date, examining leg bypass surgery in patients with severe PAD and is studying angioplasty and bypass surgery failure and approaches to identify patients at risk.

Conte earned a medical degree at Albert Einstein College of Medicine in New York City. He completed a surgical residency at New York Hospital-Cornell Medical Center and vascular surgery training as a John Homan's Fellow at Brigham and Women's Hospital in Boston and Harvard Medical School. He is a member of the Society for Vascular Surgery and Society of University Surgeons. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He serves on the editorial boards for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery and Vascular.

Conditions & Treatments

Clinics

Center for Limb Preservation
400 Parnassus Ave., Room A-6110
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. — 5 p.m.

Vascular and Endovascular Surgery
400 Parnassus Ave., Suite A-6110
San Francisco, CA 94143
Phone: (415) 353-2357
Fax: (415) 353-2669

Hours: Monday to Friday
8 a.m. – 5 p.m.

Vascular Laboratories at Parnassus
505 Parnassus Ave., Eighth Floor, Room M-830A
San Francisco, CA 94143
Phone: (415) 353-1286
Fax: (415) 353-8706

Hours: Monday to Friday
9 a.m. – 5:30 p.m.

More about Michael S. Conte

Additional Languages

Spanish

Education

Albert Einstein College of Medicine 1986

Residencies

Cornell Medical Center, General Surgery 1993

Fellowships

Brigham and Women's Hospital, Vascular Surgery 1991
Harvard Medical School, Vascular Surgery 1994
Brigham and Women's Hospital, Vascular Surgery 1994

Selected Research and Publications

  1. Pillai PS, Leeson S, Porter TF, Owens CD, Kim JM, Conte MS, Serhan CN, Gelman S. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation. 2012 Feb; 35(1):98-113.
  2. Pillai PS, Leeson S, Porter TF, Owens CD, Kim JM, Conte MS, Serhan CN, Gelman S. Erratum to: Chemical Mediators of Inflammation and Resolution in Post-Operative Abdominal Aortic Aneurysm Patients. Inflammation. 2012 Feb; 35(1):397-8.
  3. Oka RK, Conte MS, Owens CD, Rapp J, Fung G, Alley HF, Giacomini JC, Myers J, Mohler ER. Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): Protocol for randomized controlled trial. Vasc Med. 2012 Feb; 17(1):17-28.
  4. Grenon SM, Hughes-Fulford M, Rapp J, Conte MS. Polyunsaturated fatty acids and peripheral artery disease. Vasc Med. 2012 Feb; 17(1):51-63.
  5. Nabzdyk CS, Lancero H, Nguyen KP, Salek S, Conte MS. RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2011 Nov; 301(5):H1841-9.
  6. Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling. J Vasc Surg. 2011 Nov; 54(5):1383-9.
  7. Conte MS. Regarding "results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial". J Vasc Surg. 2011 May; 53(5):1453-4; author reply 1454.
  8. Bafford R, Sui XX, Park M, Miyahara T, Newfell BG, Jaffe IZ, Romero JR, Adler GK, Williams GH, Khalil RA, Conte MS. Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization. Am J Physiol Heart Circ Physiol. 2011 Jul; 301(1):H41-7.
  9. Owens CD, Gasper WJ, Conte MS. Assessing drug elution technologies in the superficial femoral artery. Panminerva Med. 2011 Mar; 53(1):37-49.
  10. Goodney PP, Schanzer A, Demartino RR, Nolan BW, Hevelone ND, Conte MS, Powell RJ, Cronenwett JL. Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg. 2011 Jul; 54(1):100-108.e4.
  11. Conte MS. Discussion. Open surgical revascularization for wound healing: past performance and future directions; and Critical evaluation of endovascular surgery for limb salvage. Plast Reconstr Surg. 2011 Jan; 127 Suppl 1:174S-176S.
  12. Gabriele R, Conte M, Bellini A, Borghese M. Analysis of variables predictive of severity in biliary peritonitis. G Chir. 2010 Oct; 31(10):435-8.
  13. Owens CD, Wake N, Kim JM, Hentschel D, Conte MS, Schanzer A. Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease. J Vasc Access. 2010 Oct-Dec; 11(4):329-34.
  14. Conte MS. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. J Vasc Surg. 2010 Sep; 52(3 Suppl):96S-103S.
  15. Conte MS. Understanding objective performance goals for critical limb ischemia trials. Semin Vasc Surg. 2010 Sep; 23(3):129-37.
  16. Conte MS. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. J Am Podiatr Med Assoc. 2010 Sep-Oct; 100(5):429-38.
  17. Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol. 2010 Oct; 177(4):2116-23.
  18. Avanzini S, Guida E, Conte M, Faranda F, Buffa P, Granata C, Castagnola E, Fratino G, Mameli L, Michelazzi A, Pini-Prato A, Mattioli G, Molinari AC, Lanino E, Jasonni V. Shifting from open surgical cut down to ultrasound-guided percutaneous central venous catheterization in children: learning curve and related complications. Pediatr Surg Int. 2010 Aug; 26(8):819-24.
  19. Grenon SM, Conte MS. Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial index. Evid Based Med. 2010 Aug; 15(4):106-8.
  20. Conte MS. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J Vasc Surg. 2010 May; 51(5 Suppl):69S-75S.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2012 The Regents of The University of California